Related Experiment Video
Updated: Aug 8, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Abstract:
Drug-metabolizing enzymes function in the biotransformation of both endogenous and exogenous lipophilic compounds. Phylogenetic studies indicate that the drug-metabolizing enzymes were a late evolutionary development. Stimuli for the evolution of these enzymes were probably movement to a terrestrial environment, a diet of higher plants and an increasing tissue specialization, with a consequential need for the formation and inactivation of hormones, bile salts etc. Most drug-metabolizing enzymes exist in multiple forms. Some are concerned solely with the metabolism of a very limited range of endogenous lipids; others such as 'phenobarbitone-type cytochrome P-450' seem to be concerned mainly wih the metabolism of exogenous compounds. In mammals the liver and intestine have a major role in the biotransformation of exogenous compounds, whereas in other tissues the primary function of the drug-metabolizing enzymes appears to be the metabolism of endogenous lipids such as steroids, lipid-soluble vitamins and fatty acids.
More Related Videos
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Related Concept Videos
Drug Biotransformation: Overview
Drug Metabolism: Phase II Reactions
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in determining the metabolic...
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes